Skip to main content
TipRanks
Go Ultimate75% OFF

Entera Bio (5DT) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Entera Bio has a market cap or net worth of EUR 491.34M. The enterprise value is EUR 150.15M.

Market Cap
EUR 491.34M
Enterprise Value
EUR 150.15M

Share Statistics

Entera Bio has 174,137,770 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
174,137,770
Owned by Insiders
1.34%
Owned by Institutions
21.08%

Financial Efficiency

Entera Bio’s return on equity (ROE) is -0.87 and return on invested capital (ROIC) is -218.81%.

Return on Equity (ROE)
-0.87
Return on Assets (ROA)
-0.72
Return on Invested Capital (ROIC)
-218.81%
Return on Capital Employed (ROCE)
-0.84
Revenue Per Employee
1,555.556
Profits Per Employee
-423.67K
Employee Count
27
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Entera Bio is -8.00. Entera Bio’s PEG ratio is 0.18.

PE Ratio
-8.00
PS Ratio
0.00
PB Ratio
1.64
Price to FCF
-33.78
Price to Operating Cash Flow
-28.23
PEG Ratio
0.18

Income Statement

In the last 12 months, Entera Bio had revenue of 42.00K and earned -11.44M in profits. Earnings per share was -0.25.

Revenue
42.00K
Gross Profit
0
Operating Income
-11.53M
Pretax Income
-11.44M
Net Income
-11.44M
EBITDA
-11.41M
Earnings Per Share (EPS)
-0.25

Cash Flow

In the last 12 months, operating cash flow was -15.98M and capital expenditures -53,836, giving a free cash flow of -16.03M billion.

Operating Cash Flow
-15.98M
Free Cash Flow
-16.03M
Free Cash Flow per Share
-0.11

Dividends & Yields

Entera Bio pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-2.96%
Earnings Yield
-6.52%

Stock Price Statistics

Beta
0.68
52-Week Price Change
20.93%
50-Day Moving Average
2.49
200-Day Moving Average
1.68
Relative Strength Index (RSI)
64.05
Average Volume (3m)
794

Important Dates

Entera Bio upcoming earnings date is Mar 26, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 06, 2026
Next Earnings Date
Mar 26, 2027
Ex-Dividend Date
―

Financial Position

Entera Bio as a current ratio of 3.23, with Debt / Equity ratio of 3.74%

Current Ratio
3.23
Quick Ratio
3.23
Debt to Market Cap
0.00
Net Debt to EBITDA
0.58
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Entera Bio has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Entera Bio EV to EBITDA ratio is -15.07, with an EV/FCF ratio of -17.22.

EV to Sales
0.00
EV to EBITDA
-15.07
EV to Free Cash Flow
-17.22
EV to Operating Cash Flow
-17.28

Balance Sheet

Entera Bio has EUR 265.88M in cash and marketable securities with EUR 397.00K in debt, giving a net cash position of EUR 265.49M billion.

Cash & Marketable Securities
EUR 265.88M
Total Debt
EUR 397.00K
Net Cash
EUR 265.49M
Net Cash Per Share
EUR 1.52
Tangible Book Value Per Share
EUR 1.89

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Entera Bio is EUR 8.91, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
EUR 8.91
Price Target Upside
211.55% Upside
Analyst Consensus
Strong Buy
Analyst Count
4
Revenue Growth Forecast
-100.00%
EPS Growth Forecast
-52.24%

Scores

Smart Score
6
AI Score
―